Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

Brittney S. Harrington(Translational Research Institute), John D. Hooper(Mater Research)
British Journal of Cancer
February 1, 2016
Cited by 82


Related Papers